Partner Headlines - ILMN

  1. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD
  2. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga
  3. Illumina Joins Drugmakers To Make Cancer Test System

    IBD
  4. Illumina: Making Markets By Unlocking The Genome

    IBD
  5. Illumina lines up key partners

    IBD
  6. Illumina Forms Partnerships With Big Pharma Firms

    IBD
  7. Stocks Open Higher, Turn Mixed; Illumina Rises, Autohome Slips

    IBD
  8. US Stock Futures Surge Ahead Of Economic Data

    Benzinga
  9. Markets Mostly Higher Despite Initial Negative Reaction From ...

    Benzinga
  10. Wedbush Upgrades Illumina To Outperform, Shares Rise

    Benzinga
  11. Stocks Shave Down Early Losses; Spirit Airlines, Illumina Climb

    IBD
  12. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  13. UPDATE: Stifel Nicolaus Initiates Coverage on Illumina, Inc. ...

    Benzinga
  14. Benzinga's Top Initiations

    Benzinga
  15. Stifel Nicolaus Initiates Illumina At Buy

    Benzinga
  16. Stocks Hold Gains Midday; Walgreen Recoups Losses

    IBD
  17. UPDATE: Tigress Initiates Coverage On Illumina

    Benzinga
  18. Top Insider Sells Highlight: Illumina Inc.

    GuruFocus
  19. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  20. Stock Indexes Nearly Flat, But Apparel, Paper, Internet Shine

    IBD
  21. Under Armour, Facebook Soar As Nasdaq Turns Positive

    IBD
  22. Illumina reports robust Q2

    IBD
  23. Stocks Open Low And Soft; Baidu, Kandi, Diamonback Rise

    IBD
  24. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  25. Illumina Names Tina S. Nova As Senior Vice Pres And General Manager ...

    Benzinga
  26. Some Stock Leaders Stay Firm Amid Pullback

    IBD
  27. Several Big Cap 20 Names Near Buy Points

    IBD
  28. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD
  29. Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

    IBD
  30. Stocks Mixed In Late Trade, But Growth Stocks Outperform

    IBD
  31. Nasdaq Showing Outperformance; GoPro Extends Gains

    IBD
  32. Novo, Other Medicals Display Healthy Action

    IBD
  33. 3 Hot Biotech Stocks Hitting Highs

    Benzinga
  34. Facebook Pops, But Key Indexes End Flat In Quiet Session

    IBD
  35. A Few Medical Research Stocks Break Out, Others Basing

    IBD
  36. Stocks Hold Near Highs; Illumina Breakout Gains Traction

    IBD
  37. Stocks Build On Gains Backed By Strong Volume

    IBD
  38. Stocks Show Solid Gains At Midday

    IBD
  39. Stocks Reverse Into Thin Losses; Joy Global, Illumina Rocket

    IBD
  40. Five Star Biotech Stock Watch: Illumina

    Benzinga
  41. Baron Funds Comments on Illumina Inc.

    GuruFocus
  42. Baron Funds Comments on Illumina Inc.

    GuruFocus
  43. Valeant, Tesla Working On Bases As Energy Dominates

    IBD
  44. Baron Funds Comments on Illumina Inc.

    GuruFocus
  45. Nasdaq Recovers After Early Weakness; Apple Rallies Again

    IBD
  46. Illumina Reports Filing of New Patent Infringement Case Against ...

    Benzinga
  47. Gilead, Illumina Q1 Earnings Win Wall Street's Love

    IBD
  48. Stock Futures Mixed And Busy; Illumina Rockets, Cree Tumbles

    IBD
  49. Gilead, Illumina Crush Views

    IBD
  50. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  51. Stocks Rise; Valeant, Netflix Soar After Hours

    IBD
  52. Analyst Bullish On Medical Research, Equipment Stocks

    IBD
  53. How To Tweak Your Retirement Portfolio For 2014 Market

    IBD
  54. Medical Research Providers Ride Higher With Biotechs

    IBD
  55. Illumina, Alexion Lead 4 Big Caps Drawing Big Buyers

    IBD
  56. Gap-Ups Point To Strength Among Select Big Caps

    IBD
  57. Illumina Inc: How Long Can a Miracle Go On?

    GuruFocus
  58. LinkedIn, TripAdvisor, Google: Top Manager's Ideas

    IBD
  59. Facebook, Biogen, Sands Among Top Big Caps Reporting

    IBD
  60. ILLUMINA

    IBD
  61. Illumina, Jazz Among 5 Young Guns Hitting New Highs

    IBD
  62. Illumina Details Its Strategy; Stock Jumps Again

    IBD
  63. US Stock Futures Surge Ahead Of Morgan Stanley Earnings

    Benzinga
  64. Illumina Announces New Organizational Alignment -8K

    Benzinga
  65. Market Wrap For January 16: Markets End Two Day Winning Streak

    Benzinga
  66. ILLUMINA

    IBD
  67. Illumina Upbeat On Q4, 2014

    IBD
  68. Illumina, Regeneron, Intuitive Q4 Results Impress

    IBD
  69. Year in Review: 2013 Innovations

    FoxBusiness
  70. Year in Review: 2013 Innovations

    FoxBusiness
  71. Benzinga's Top Initiations

    Benzinga
  72. Illumina Receives FDA Premarket Clearance for MiSeqDx System

    Benzinga
  73. Gilead Sciences Leads In Rising Short Interest Among Biotechs ...

    Benzinga
  74. Illumina Appoints Francis deSouza as President

    Benzinga
  75. Syntrix Biosystems Announces Court Upholds $115M Patent Infringement ...

    Benzinga
  76. Vipshop, 3D Systems Lead Top 5 Outperforming Stocks

    IBD
  77. Illumina Signs Agreement to Acquire NextBio, Leader in Analyzing ...

    Benzinga
  78. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics ...

    Benzinga
  79. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  80. Illumina Announces TruGenome Undiagnosed Disease Test

    Benzinga
  81. Illumina Tops Q3 Profit, Sales

    IBD
  82. Illumina Earnings, Guidance Beat Estimates Yet Again

    IBD
  83. Earnings Scheduled For October 21, 2013

    Benzinga
  84. Illumina Collaborates with University of Cambridge, Genomics ...

    Benzinga
  85. Illumina's Verinata Health Reports Expanded Test of Verifi for ...

    Benzinga
  86. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  87. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, ...

    Benzinga
  88. Illumina Applies CE Mark to Expanded MiSeqDx™ System

    Benzinga
  89. Illumina's Verinata Reports Non-invasive Verifi Prenatal Test2 ...

    Benzinga
  90. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    Benzinga
  91. UPDATE: Wells Fargo Initiates Coverage on Illumina on Prime Market ...

    Benzinga
  92. Sony and Illumina Set to Change the Way Doctors Identify and ...

    Benzinga
  93. Illumina to Supply Natera with Sequencing Instruments, Consumables ...

    Benzinga
  94. Drug R&D Suppliers Deliver

    IBD
  95. Medical Research Firms Tap Drug Development Trend

    IBD
  96. Medical Research Firms Tap Drug Development Trend

    IBD
  97. Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, ...

    Benzinga
  98. Illumina, Grifols, Acadia Resist The Correction

    IBD
  99. Benzinga's M&A Chatter for Monday August 12, 2013

    Benzinga
  100. Baron Funds Comments on Illumina Inc.

    GuruFocus
Trading Center